Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Colorectal Neoplasms

  Free Subscription


Articles published in Ann Surg

Retrieve available abstracts of 169 articles:
HTML format



Single Articles


    July 2021
  1. LOUGHREY MB, Webster F, Arends MJ, Brown I, et al
    Dataset for Pathology Reporting of Colorectal Cancer: Recommendations from the International Collaboration on Cancer Reporting (ICCR).
    Ann Surg. 2021 Jul 7. pii: 00000658-900000000-93438.
    PubMed     Abstract available


    May 2021
  2. BALVARDI S, Pecorelli N, Castelino T, Niculiseanu P, et al
    Impact of Facilitation of Early Mobilization on Postoperative Pulmonary Outcomes After Colorectal Surgery: A Randomized Controlled Trial.
    Ann Surg. 2021;273:868-875.
    PubMed     Abstract available


    April 2021
  3. KEMENY NE, Chou JF, Capanu M, Chatila WK, et al
    A Randomized Phase II Trial of Adjuvant Hepatic Arterial Infusion and Systemic Therapy with or without Panitumumab after Hepatic Resection of KRAS Wild-Type Colorectal Cancer.
    Ann Surg. 2021 Apr 30. pii: 00000658-900000000-93567.
    PubMed     Abstract available


  4. ONERUP A, Andersson J, Angenete E, Bock D, et al
    Effect of Short-Term Homebased Pre- and Postoperative Exercise on Recovery after Colorectal Cancer Surgery (PHYSSURG-C): A Randomized Clinical Trial.
    Ann Surg. 2021 Apr 9. pii: 00000658-900000000-93606.
    PubMed     Abstract available


  5. CURTIS NJ, Dennison G, Brown CSB, Hewett PJ, et al
    Clinical Evaluation of Intraoperative Near Misses in Laparoscopic Rectal Cancer Surgery.
    Ann Surg. 2021;273:778-784.
    PubMed     Abstract available


    March 2021
  6. HASSELGREN K, Rosok BI, Larsen PN, Sparrelid E, et al
    ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO.
    Ann Surg. 2021;273:442-448.
    PubMed     Abstract available


    February 2021
  7. ISHIBE A, Watanabe J, Ota M, Endo I, et al
    Response to Comments on "A prospective, single-arm, multicenter trial of diverting stoma followed by neoadjuvant chemotherapy using mFOLFOX6 for obstructive colon cancer: YCOG1305 (PROBE study)".
    Ann Surg. 2021 Feb 26. doi: 10.1097/SLA.0000000000004824.
    PubMed    


  8. CAZELLES A, Manceau G, Taieb J, Karoui M, et al
    Comments On "A Prospective, Single-Arm, Multicenter Trial of Diverting Stoma Followed By Neoadjuvant Chemotherapy Using mFOLFOX6 for Obstructive Colon Cancer: YCOG 1305 (PROBE study)" Ann Surg 2020 [Epub ahead of print]. DOI: 10.1097/SLA.0000000000004
    Ann Surg. 2021 Feb 18. pii: 00000658-900000000-93710.
    PubMed    


  9. ZHANG Q, Chen B, Liu ZK
    Comment on "Apical Node Involvement Does Not Influence Prognosis After Potentially Curative Resection for Stage III Colorectal Cancer, A Competing Risks Analysis".
    Ann Surg. 2021 Feb 10. pii: 00000658-900000000-93706.
    PubMed    


  10. DI BUONO G, Agrusa A
    Response to: Comment on "Feasibility and safety of laparoscopic Complete Mesocolic Excision (CME) for right-sided colon cancer: short-term outcomes. A randomized clinical study".
    Ann Surg. 2021 Feb 10. pii: 00000658-900000000-93705.
    PubMed    


  11. LU JY, Xiao Y
    Comment on "Feasibility and Safety of Laparoscopic Complete Mesocolic Excision (CME) for Right-Sided Colon Cancer: Short-term Outcomes. A Randomized Clinical Study".
    Ann Surg. 2021 Feb 10. pii: 00000658-900000000-93703.
    PubMed    


  12. STEIN SL
    Measure Twice, Cut Once.
    Ann Surg. 2021;273:195-196.
    PubMed    


    January 2021
  13. WATANABE J, Ishibe A, Suwa H, Ota M, et al
    Long-term Outcomes of a Randomized Controlled Trial of Single-incision Versus Multi-port Laparoscopic Colectomy for Colon Cancer.
    Ann Surg. 2021 Jan 28. doi: 10.1097/SLA.0000000000004252.
    PubMed     Abstract available


    December 2020
  14. HEALY MA, Peacock O, Hu CY, Bednarski BK, et al
    High Rate of Positive Circumferential Resection Margin in Colon Cancer: A National Appraisal and Call for Action.
    Ann Surg. 2020 Dec 22. doi: 10.1097/SLA.0000000000004682.
    PubMed     Abstract available


  15. OKUGAWA Y, Toiyama Y, Ohi M, Kusunoki M, et al
    Response to the Comment on "Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer".
    Ann Surg. 2020;Publish Ahead of Print.
    PubMed    


  16. KUDOSE Y, Ahiko Y, Shida D
    Response to: Comment on "Evaluation of Recurrence Risk After Curative Resection for Patients With Stage I to III Colorectal Cancer Using the Hazard Function: Retrospective Analysis of a Single-institution Large Cohort".
    Ann Surg. 2020;Publish Ahead of Print.
    PubMed    


  17. WANG X, Zheng Z, Chi P
    Comment on "Evaluation of Recurrence Risk After Curative Resection for Patients With Stage I to III Colorectal Cancer Using the Hazard Function: Retrospective Analysis of a Single-institution Large Cohort".
    Ann Surg. 2020;Publish Ahead of Print.
    PubMed    


  18. DENG X, Liu P, Jiang D, Wei M, et al
    Neoadjuvant Radiotherapy Versus Surgery Alone for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors: A Prospective Multicenter Stratified Randomized Trial.
    Ann Surg. 2020;272:1060-1069.
    PubMed     Abstract available


  19. YAMASHITA S, Chun YS, Kopetz SE, Maru D, et al
    APC and PIK3CA Mutational Cooperativity Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colorectal Liver Metastases.
    Ann Surg. 2020;272:1080-1085.
    PubMed     Abstract available


    November 2020
  20. POULSON M, Cornell E, Madiedo A, Kenzik K, et al
    The Impact of Racial Residential Segregation on Colorectal Cancer Outcomes and Treatment.
    Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004653.
    PubMed     Abstract available


  21. TRILLING B, Delattre F, Faucheron JL
    Comment on "Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer: Three-year Results From a Prospective, Nonrandomized, Double-blind, Controlled Trial".
    Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004403.
    PubMed    


  22. GAO Z, Wang C, Jiang K, Shen Z, et al
    Response to the Comment on "Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer: Three-year Results from a Prospective, Nonrandomized, Double-blind, Controlled Trial".
    Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004394.
    PubMed    


  23. GAO Z, Wang C, Tao Z, Ye Y, et al
    Response to Comment on "Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer: Three-year Results From a Prospective, Nonrandomized, Double-blind, Controlled Trial".
    Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004273.
    PubMed    


  24. ZHU D, Xia J, Gu Y, Lin J, et al
    Preoperative Hepatic and Regional Arterial Chemotherapy in Patients Who Underwent Curative Colorectal Cancer Resection: A Prospective, Multi-Center, Randomized Controlled Trial.
    Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004558.
    PubMed     Abstract available


  25. DI BUONO G, Buscemi S, Cocorullo G, Sorce V, et al
    Feasibility and Safety of Laparoscopic Complete Mesocolic Excision (CME) for Right-Sided Colon Cancer: Short-Term Outcomes. A Randomized Clinical Study.
    Ann Surg. 2020 Nov 9. doi: 10.1097/SLA.0000000000004557.
    PubMed     Abstract available


  26. PETROWSKY H, Linecker M, Raptis DA, Kuemmerli C, et al
    First Long-term Oncologic Results of the ALPPS Procedure in a Large Cohort of Patients With Colorectal Liver Metastases.
    Ann Surg. 2020;272:793-800.
    PubMed     Abstract available


  27. IGNATAVICIUS P, Oberkofler CE, Chapman WC, DeMatteo RP, et al
    Choices of Therapeutic Strategies for Colorectal Liver Metastases Among Expert Liver Surgeons: A Throw of the Dice?
    Ann Surg. 2020;272:715-722.
    PubMed     Abstract available


  28. AREZZO A, Forcignano E, Bonino MA, Balague C, et al
    Long-term Oncologic Results After Stenting as a Bridge to Surgery Versus Emergency Surgery for Malignant Left-sided Colonic Obstruction: A Multicenter Randomized Controlled Trial (ESCO Trial).
    Ann Surg. 2020;272:703-708.
    PubMed     Abstract available


    October 2020
  29. GLEASON F, Chu DI, Kennedy GD, Kenzik KM, et al
    Early Elective Surgery After Colon Cancer Diagnosis has Higher Risk of Readmission and Death.
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004431.
    PubMed     Abstract available


  30. NG KS, Dent OF, Chan C, Newland RC, et al
    Apical Node Involvement Does Not Influence Prognosis After Potentially Curative Resection for Stage III Colorectal Cancer: A Competing Risks Analysis.
    Ann Surg. 2020 Oct 14. doi: 10.1097/SLA.0000000000004353.
    PubMed     Abstract available


  31. SOUADKA A, Majbar MA, Essangri H, Benkabbou A, et al
    Comment on "Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer: Three-Year Results From a Prospective, Nonrandomized, Double-Blind, Controlled Trial".
    Ann Surg. 2020 Oct 14. doi: 10.1097/SLA.0000000000004284.
    PubMed    


    September 2020
  32. ISHIBE A, Watanabe J, Suwa Y, Nakagawa K, et al
    A prospective, single-arm, multicenter trial of diverting stoma followed by neoadjuvant chemotherapy using mFOLFOX6 for obstructive colon cancer: YCOG 1305 (PROBE study).
    Ann Surg. 2020 Sep 15. doi: 10.1097/SLA.0000000000004494.
    PubMed     Abstract available


    August 2020
  33. VELD JV, Amelung FJ, Borstlap WAA, van Halsema EE, et al
    Decompressing Stoma as Bridge to Elective Surgery is an Effective Strategy for Left-sided Obstructive Colon Cancer: A National, Propensity-score Matched Study.
    Ann Surg. 2020 Aug 21. doi: 10.1097/SLA.0000000000004173.
    PubMed     Abstract available


  34. OKUGAWA Y, Toiyama Y, Yamamoto A, Shigemori T, et al
    Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer.
    Ann Surg. 2020;272:342-351.
    PubMed     Abstract available


  35. O'LEARY MP, Choong KC, Thornblade LW, Fakih MG, et al
    Management Considerations for the Surgical Treatment of Colorectal Cancer During the Global Covid-19 Pandemic.
    Ann Surg. 2020;272:e98-e105.
    PubMed     Abstract available


  36. GHOLAMI S, Kemeny NE, Boucher TM, Gonen M, et al
    Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients.
    Ann Surg. 2020;272:352-356.
    PubMed     Abstract available


  37. SYN NL, Kabir T, Koh YX, Tan HL, et al
    Survival Advantage of Laparoscopic Versus Open Resection For Colorectal Liver Metastases: A Meta-analysis of Individual Patient Data From Randomized Trials and Propensity-score Matched Studies.
    Ann Surg. 2020;272:253-265.
    PubMed     Abstract available


    July 2020
  38. ARRINGTON AK, O'Grady C, Schaefer K, Khreiss M, et al
    Significance of Lymph Node Resection After Neoadjuvant Therapy in Pancreatic, Gastric, and Rectal Cancers.
    Ann Surg. 2020 Jul 24. doi: 10.1097/SLA.0000000000004181.
    PubMed     Abstract available


  39. YUAN Z, Xu T, Cai J, Zhao Y, et al
    Development and Validation of an Image-based Deep Learning Algorithm for Detection of Synchronous Peritoneal Carcinomatosis in Colorectal Cancer.
    Ann Surg. 2020 Jul 16. doi: 10.1097/SLA.0000000000004229.
    PubMed     Abstract available


  40. SAO JULIAO GP, Karagkounis G, Fernandez LM, Habr-Gama A, et al
    Conditional Survival in Patients With Rectal Cancer and Complete Clinical Response Managed by Watch and Wait After Chemoradiation: Recurrence Risk Over Time.
    Ann Surg. 2020;272:138-144.
    PubMed     Abstract available


    June 2020
  41. KUDOSE Y, Shida D, Ahiko Y, Nakamura Y, et al
    Evaluation of Recurrence Risk After Curative Resection for Patients With Stage I to III Colorectal Cancer Using the Hazard Function: Retrospective Analysis of a Single-institution Large Cohort.
    Ann Surg. 2020 Jun 11. doi: 10.1097/SLA.0000000000004058.
    PubMed     Abstract available


  42. ZHANG QX, Xu BB, Xue Z
    Comment on "Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer".
    Ann Surg. 2020 Jun 4. doi: 10.1097/SLA.0000000000003856.
    PubMed    


  43. DEERY SE, Cavallaro PM, McWalters ST, Reilly SR, et al
    Colorectal Surgical Site Infection Prevention Kits Prior to Elective Colectomy Improve Outcomes.
    Ann Surg. 2020;271:1110-1115.
    PubMed     Abstract available


    May 2020
  44. O'LEARY MP, Choong KC, Thornblade LW, Fakih MG, et al
    Management Considerations for the Surgical Treatment of Colorectal Cancer During the Global Covid-19 Pandemic.
    Ann Surg. 2020 May 22. doi: 10.1097/SLA.0000000000004029.
    PubMed     Abstract available


  45. AZOULAY D, Lim C
    Comment on "Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases": Shaking the Coconut Tree.
    Ann Surg. 2020;271:e122-e124.
    PubMed    


  46. DUELAND S, Line PD
    Response to the Comment on"Survival Following Liver Transplantation for Patients With Non-resectable Liver Only Colorectal Metastases": What if those Lesions Are Gone?
    Ann Surg. 2020;271:e124.
    PubMed    


    April 2020
  47. KAROUI M, Rullier A, Piessen G, Legoux JL, et al
    Perioperative FOLFOX 4 Versus FOLFOX 4 Plus Cetuximab Versus Immediate Surgery for High-Risk Stage II and III Colon Cancers: A Phase II Multicenter Randomized Controlled Trial (PRODIGE 22).
    Ann Surg. 2020;271:637-645.
    PubMed     Abstract available


  48. BLOK RD, Hagemans JAW, Klaver CEL, Hellinga J, et al
    A Systematic Review and Meta-analysis on Omentoplasty for the Management of Abdominoperineal Defects in Patients Treated for Cancer.
    Ann Surg. 2020;271:654-662.
    PubMed     Abstract available


  49. HASAN S, Renz P, Wegner RE, Finley G, et al
    Microsatellite Instability (MSI) as an Independent Predictor of Pathologic Complete Response (PCR) in Locally Advanced Rectal Cancer: A National Cancer Database (NCDB) Analysis.
    Ann Surg. 2020;271:716-723.
    PubMed     Abstract available


    March 2020
  50. BOUDJEMA K, Locher C, Sabbagh C, Ortega-Deballon P, et al
    Simultaneous Versus Delayed Resection for Initially Resectable Synchronous Colorectal Cancer Liver Metastases: A Prospective, Open-label, Randomized, Controlled Trial.
    Ann Surg. 2020 Mar 20. doi: 10.1097/SLA.0000000000003848.
    PubMed     Abstract available


  51. LEE YS, Kim JH, Kim HJ, Lee SC, et al
    Short-term Outcomes of Single-port Versus Multiport Laparoscopic Surgery for Colon Cancer: The SIMPLE Multicenter Randomized Clinical Trial.
    Ann Surg. 2020 Mar 20. doi: 10.1097/SLA.0000000000003882.
    PubMed     Abstract available


  52. RONNOW CF, Arthursson V, Toth E, Krarup PM, et al
    Lymphovascular Infiltration, Not Depth of Invasion, is the Critical Risk Factor of Metastases in Early Colorectal Cancer: Retrospective Population-based Cohort Study on Prospectively Collected Data, Including Validation.
    Ann Surg. 2020 Mar 13. doi: 10.1097/SLA.0000000000003854.
    PubMed     Abstract available


  53. PETRELLI F, Trevisan F, Cabiddu M, Sgroi G, et al
    Total Neoadjuvant Therapy in Rectal Cancer: A Systematic Review and Meta-analysis of Treatment Outcomes.
    Ann Surg. 2020;271:440-448.
    PubMed     Abstract available


    February 2020
  54. SABBAGH C, Manceau G, Mege D, Abdalla S, et al
    Is Adjuvant Chemotherapy Necessary for Obstructing Stage II Colon Cancer? Results From a Propensity Score Analysis of the French Surgical Association Database.
    Ann Surg. 2020 Feb 14. doi: 10.1097/SLA.0000000000003832.
    PubMed     Abstract available


  55. CHUN YS, Vauthey JN
    Response to Comment on "Deleterious Effect of RAS and Evolutionary High Risk TP53 Double Mutation in Colorectal Liver Metastases".
    Ann Surg. 2020;271:e16-e17.
    PubMed    


  56. WARD J, Soonawalla Z, Silva M
    Comment on "Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases".
    Ann Surg. 2020;271:e15-e16.
    PubMed    


  57. ZHAO X, Wang C, Li Z
    Comment on "Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases".
    Ann Surg. 2020;271:e16.
    PubMed    


    January 2020
  58. AHL R, Matthiessen P, Fang X, Cao Y, et al
    beta-Blockade in Rectal Cancer Surgery: A Simple Measure of Improving Outcomes.
    Ann Surg. 2020;271:140-146.
    PubMed     Abstract available


  59. GAGNIERE J, Dupre A, Gholami SS, Pezet D, et al
    Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients.
    Ann Surg. 2020;271:147-154.
    PubMed     Abstract available


    December 2019
  60. KALTENMEIER C, Shen C, Medich DS, Geller DA, et al
    Time to Surgery and Colon Cancer Survival in the United States.
    Ann Surg. 2019 Dec 10. doi: 10.1097/SLA.0000000000003745.
    PubMed     Abstract available


  61. ROSEN CB, Nagorney DM, Alberts SR
    Is There a Role for Liver Transplantation in the Treatment of Patients With Metastatic Colorectal Cancer?
    Ann Surg. 2019 Dec 5. doi: 10.1097/SLA.0000000000003713.
    PubMed    


  62. ACUNA SA, Chesney TR, Baxter NN
    Response to Comment on "Routine Use of Laparoscopic Surgery for Rectal Cancer".
    Ann Surg. 2019;270:e146-e147.
    PubMed    


  63. CHEN HL, Song YP, Liu K
    Comment on "Routine Use of Laparoscopic Surgery for Rectal Cancer".
    Ann Surg. 2019;270:e145-e146.
    PubMed    


  64. KANEMOTO Y, Kurokawa T, Tanimoto T
    Comment on "Organ Preservation in cT2N0 Rectal Cancer After Neoadjuvant Chemoradiation Therapy".
    Ann Surg. 2019;270:e118-e119.
    PubMed    


  65. HABR-GAMA A, Sao Juliao GP, Vailati BB, Fernandez LM, et al
    Response to Comment on "Organ Preservation for cT2N0 Distal Rectal Cancer-Are There Any Better Surgical Alternatives Without Chemoradiation?"
    Ann Surg. 2019;270:e119-e120.
    PubMed    


  66. D'SOUZA N, de Neree Tot Babberich MPM, d'Hoore A, Tiret E, et al
    Definition of the Rectum: An International, Expert-based Delphi Consensus.
    Ann Surg. 2019;270:955-959.
    PubMed     Abstract available


  67. GUERRA F, Giuliani G
    Comment on "Robot-assisted Versus Laparoscopic Surgery for Rectal Cancer: A Phase II Open Label Prospective Randomized Controlled Trial".
    Ann Surg. 2019;270:e103-e104.
    PubMed    


  68. DORCARATTO D, Mazzinari G, Fernandez M, Munoz E, et al
    Impact of Postoperative Complications on Survival and Recurrence After Resection of Colorectal Liver Metastases: Systematic Review and Meta-analysis.
    Ann Surg. 2019;270:1018-1027.
    PubMed     Abstract available


  69. FUJITA S
    Response to Comment on "Letter to the Editor".
    Ann Surg. 2019;270:e81-e82.
    PubMed    


  70. CIROCCHI R, Graziosi L, D'Andrea V, Popivanov GI, et al
    Comment on "Is the Routine Dissection of Lateral Lymph Nodes Really Necessary After Mesorectal Excision for Clinical Stage II/III Lower Rectal Cancer?"
    Ann Surg. 2019;270:e80-e81.
    PubMed    


  71. LEE L, de Lacy B, Gomez Ruiz M, Liberman AS, et al
    A Multicenter Matched Comparison of Transanal and Robotic Total Mesorectal Excision for Mid and Low-rectal Adenocarcinoma.
    Ann Surg. 2019;270:1110-1116.
    PubMed     Abstract available


    November 2019
  72. ROODBEEN SX, de Lacy FB, van Dieren S, Penna M, et al
    Predictive Factors and Risk Model for Positive Circumferential Resection Margin Rate After Transanal Total Mesorectal Excision in 2653 Patients With Rectal Cancer.
    Ann Surg. 2019;270:884-891.
    PubMed     Abstract available


  73. LANG H, Baumgart J, Heinrich S, Tripke V, et al
    Extended Molecular Profiling Improves Stratification and Prediction of Survival After Resection of Colorectal Liver Metastases.
    Ann Surg. 2019;270:799-805.
    PubMed     Abstract available


  74. LEFEVRE JH, Mineur L, Cachanado M, Denost Q, et al
    Does A Longer Waiting Period After Neoadjuvant Radio-chemotherapy Improve the Oncological Prognosis of Rectal Cancer?: Three Years' Follow-up Results of the Greccar-6 Randomized Multicenter Trial.
    Ann Surg. 2019;270:747-754.
    PubMed     Abstract available


  75. RAPTIS DA, Linecker M, Kambakamba P, Tschuor C, et al
    Defining Benchmark Outcomes for ALPPS.
    Ann Surg. 2019;270:835-841.
    PubMed     Abstract available


  76. ALLAIX ME, Degiuli M, Bonino MA, Arezzo A, et al
    Intracorporeal or Extracorporeal Ileocolic Anastomosis After Laparoscopic Right Colectomy: A Double-blinded Randomized Controlled Trial.
    Ann Surg. 2019;270:762-767.
    PubMed     Abstract available


  77. TSAI AY, Mavroveli S, Miskovic D, van Oostendorp S, et al
    Surgical Quality Assurance in COLOR III: Standardization and Competency Assessment in a Randomized Controlled Trial.
    Ann Surg. 2019;270:768-774.
    PubMed     Abstract available


    September 2019
  78. GORGEN A, Sapisochin G
    Comment on "Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases": What if Those Lesions are Gone?
    Ann Surg. 2019 Sep 24. doi: 10.1097/SLA.0000000000003606.
    PubMed    


  79. FENTON HM, Taylor JC, Lodge JPA, Toogood GJ, et al
    Variation in the Use of Resection for Colorectal Cancer Liver Metastases.
    Ann Surg. 2019 Sep 16. doi: 10.1097/SLA.0000000000003534.
    PubMed     Abstract available


    August 2019
  80. RAOOF M, Haye S, Ituarte PHG, Fong Y, et al
    Liver Resection Improves Survival in Colorectal Cancer Patients: Causal-Effects From Population-Level Instrumental Variable Analysis.
    Ann Surg. 2019 Aug 29. doi: 10.1097/SLA.0000000000003485.
    PubMed     Abstract available


  81. GAO Z, Wang C, Zhan S, Tao Z, et al
    Response to Comment on "Controlling for Ascertainment Bias May Introduce Control Group Bias in Prospective Nonrandomized Trials".
    Ann Surg. 2019;270:e55.
    PubMed    


  82. SIMILLIS C, Tekkis PP
    Comment on "Robotic Versus Laparoscopic Surgery for Rectal Cancer: An Evidence-based Approach".
    Ann Surg. 2019;270:e57.
    PubMed    


  83. PRETE FP, Prete F, Strippoli GFM
    Response to Comment on "Robotic Versus Laparoscopic Surgery for Rectal Cancer: An Evidence-based Approach".
    Ann Surg. 2019;270:e57-e58.
    PubMed    


  84. GACHABAYOV M, Dyatlov A, Bergamaschi R
    Comment on "Controlling for Ascertainment Bias May Introduce Control Group Bias in Prospective Nonrandomized Trials".
    Ann Surg. 2019;270:e54-e55.
    PubMed    


  85. MARTINEZ-PEREZ A, de'Angelis N
    Comment on "Mid-term Results of ACOSOG Z6051 Trial Sustain the Unresolved Debate".
    Ann Surg. 2019;270:e52-e53.
    PubMed    


  86. FLESHMAN J
    Response to Comment on "Letter to the Editor for Z6051 (Revised 11/14/18)".
    Ann Surg. 2019;270:e53-e54.
    PubMed    


  87. BIONDI A, Persiani R
    Comment on "Distal Resection Margin Status in Transanal Total Mesorectal Excision (TA-TME)".
    Ann Surg. 2019;270:e34-e35.
    PubMed    


  88. SANDSTROM P, Larsson AL, Bjornsson B, Rosok BI, et al
    Response to Comment on "When Innovation Is Not Enough".
    Ann Surg. 2019;270:e36-e37.
    PubMed    


  89. VEGA EA, Simoneau E, Tzeng CD, Odisio BC, et al
    Comment on Letter to the Editor Regarding "ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis: When Innovation is Not Enough".
    Ann Surg. 2019;270:e35-e36.
    PubMed    


  90. HAUSKEN J, Fretland AA, Edwin B, Andersen MH, et al
    Intravenous Patient-controlled Analgesia Versus Thoracic Epidural Analgesia After Open Liver Surgery: A Prospective, Randomized, Controlled, Noninferiority Trial.
    Ann Surg. 2019;270:193-199.
    PubMed     Abstract available


    July 2019
  91. JONES EL, Halpern AL, Carmichael H, Wikiel KJ, et al
    Hepatic Ablation Promotes Colon Cancer Metastases in an Immunocompetent Murine Model.
    Ann Surg. 2019 Jul 23. doi: 10.1097/SLA.0000000000003474.
    PubMed     Abstract available


  92. TREPANIER M, Minnella EM, Paradis T, Awasthi R, et al
    Improved Disease-Free Survival After Prehabilitation for Colorectal Cancer Surgery.
    Ann Surg. 2019 Jul 15. doi: 10.1097/SLA.0000000000003465.
    PubMed     Abstract available


  93. FAUCHERON JL, Sage PY, Trilling B
    Comment on "What Expert Surgeons Never Tell You About Robot-assisted Surgery for Rectal Cancer?"
    Ann Surg. 2019;270:e10-e11.
    PubMed    


  94. SIMILLIS C, Lal N, Thoukididou SN, Kontovounisios C, et al
    Open Versus Laparoscopic Versus Robotic Versus Transanal Mesorectal Excision for Rectal Cancer: A Systematic Review and Network Meta-analysis.
    Ann Surg. 2019;270:59-68.
    PubMed     Abstract available


    June 2019
  95. RASKOV H, Soby JH, Troelsen J, Bojesen RD, et al
    Driver Gene Mutations and Epigenetics in Colorectal Cancer.
    Ann Surg. 2019 Jun 7. doi: 10.1097/SLA.0000000000003393.
    PubMed     Abstract available


  96. DUELAND S, Syversveen T, Solheim JM, Solberg S, et al
    Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases.
    Ann Surg. 2019 Jun 7. doi: 10.1097/SLA.0000000000003404.
    PubMed     Abstract available


  97. MARGONIS GA, Buettner S, Andreatos N, Wagner D, et al
    Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases: A Multi-institutional, International Analysis of 1099 Patients.
    Ann Surg. 2019;269:1129-1137.
    PubMed     Abstract available


  98. JUUL T, Elfeki H, Christensen P, Laurberg S, et al
    Normative Data for the Low Anterior Resection Syndrome Score (LARS Score).
    Ann Surg. 2019;269:1124-1128.
    PubMed     Abstract available


  99. KARAGKOUNIS G, Thai L, Mace AG, Wiland H, et al
    Prognostic Implications of Pathological Response to Neoadjuvant Chemoradiation in Pathologic Stage III Rectal Cancer.
    Ann Surg. 2019;269:1117-1123.
    PubMed     Abstract available


  100. MARI GM, Crippa J, Cocozza E, Berselli M, et al
    Low Ligation of Inferior Mesenteric Artery in Laparoscopic Anterior Resection for Rectal Cancer Reduces Genitourinary Dysfunction: Results From a Randomized Controlled Trial (HIGHLOW Trial).
    Ann Surg. 2019;269:1018-1024.
    PubMed     Abstract available


    May 2019
  101. VAN PRAAGH JB, de Goffau MC, Harmsen HJM, Havenga K, et al
    Response to Comment on "Mucus Microbiome of Anastomotic Tissue During Surgery Has Predictive Value for Colorectal Anastomotic Leakage".
    Ann Surg. 2019;269:e69-e70.
    PubMed    


  102. LAMENDELLA R, Stewart DB
    Comment on "Mucus Microbiome of Anastomotic Tissue During Surgery Has Predictive Value for Colorectal Anastomotic Leakage".
    Ann Surg. 2019;269:e68-e69.
    PubMed    


  103. PARC Y, Ruppert R, Fuerst A, Golcher H, et al
    Better Function With a Colonic J-Pouch or a Side-to-end Anastomosis?: A Randomized Controlled Trial to Compare the Complications, Functional Outcome, and Quality of Life in Patients With Low Rectal Cancer After a J-Pouch or a Side-to-end Anastomosis.
    Ann Surg. 2019;269:815-826.
    PubMed     Abstract available


  104. ACUNA SA, Chesney TR, Ramjist JK, Shah PS, et al
    Laparoscopic Versus Open Resection for Rectal Cancer: A Noninferiority Meta-analysis of Quality of Surgical Resection Outcomes.
    Ann Surg. 2019;269:849-855.
    PubMed     Abstract available


  105. MARTI WR, Curti G, Wehrli H, Grieder F, et al
    Clinical Outcome After Rectal Replacement With Side-to-End, Colon-J-Pouch, or Straight Colorectal Anastomosis Following Total Mesorectal Excision: A Swiss Prospective, Randomized, Multicenter Trial (SAKK 40/04).
    Ann Surg. 2019;269:827-835.
    PubMed     Abstract available


  106. CHUN YS, Passot G, Yamashita S, Nusrat M, et al
    Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases.
    Ann Surg. 2019;269:917-923.
    PubMed     Abstract available


    April 2019
  107. MARGONIS GA, Andreatos N, Wolfgang CL, Weiss MJ, et al
    Response to the Comment on "Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases."
    Ann Surg. 2019;269:e49-e51.
    PubMed    


  108. VIGANO L, Costa G, Toso C, Cimino M, et al
    Comment on "Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases."
    Ann Surg. 2019;269:e47-e49.
    PubMed    


  109. MATHIS KL, Nelson H
    Laparoscopic Proctectomy for Cancer.
    Ann Surg. 2019;269:603-604.
    PubMed    


  110. STEVENSON ARL, Solomon MJ, Brown CSB, Lumley JW, et al
    Disease-free Survival and Local Recurrence After Laparoscopic-assisted Resection or Open Resection for Rectal Cancer: The Australasian Laparoscopic Cancer of the Rectum Randomized Clinical Trial.
    Ann Surg. 2019;269:596-602.
    PubMed     Abstract available


  111. FLESHMAN J, Branda ME, Sargent DJ, Boller AM, et al
    Disease-free Survival and Local Recurrence for Laparoscopic Resection Compared With Open Resection of Stage II to III Rectal Cancer: Follow-up Results of the ACOSOG Z6051 Randomized Controlled Trial.
    Ann Surg. 2019;269:589-595.
    PubMed     Abstract available


  112. JANG JH, Kim HC, Huh JW, Park YA, et al
    Anastomotic Leak Does Not Impact Oncologic Outcomes After Preoperative Chemoradiotherapy and Resection for Rectal Cancer.
    Ann Surg. 2019;269:678-685.
    PubMed     Abstract available


    March 2019
  113. GIGLIO MC, Troisi RI
    Comment on "ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis".
    Ann Surg. 2019;269:e32.
    PubMed    


    February 2019
  114. OKUGAWA Y, Toiyama Y, Yamamoto A, Shigemori T, et al
    Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer.
    Ann Surg. 2019 Feb 16. doi: 10.1097/SLA.0000000000003239.
    PubMed     Abstract available



  115. Surgical and Survival Outcomes Following Pelvic Exenteration for Locally Advanced Primary Rectal Cancer: Results From an International Collaboration.
    Ann Surg. 2019;269:315-321.
    PubMed     Abstract available


  116. IMAI K, Benitez CC, Allard MA, Vibert E, et al
    Impact of Surgical Treatment for Recurrence After 2-Stage Hepatectomy for Colorectal Liver Metastases, on Patient Outcome.
    Ann Surg. 2019;269:322-330.
    PubMed     Abstract available


    January 2019
  117. SERENARI M, Ardiles V, Ravaioli M, Cescon M, et al
    Rapid but not Harmful: Functional Evaluation With Hepatobiliary Scintigraphy After Accelerated Liver Regeneration Techniques.
    Ann Surg. 2019 Jan 3. doi: 10.1097/SLA.0000000000003184.
    PubMed    


  118. SANDSTROM P, Rosok BI, Sparrelid E, Larsen PN, et al
    Response to "ALPPS Versus Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastases".
    Ann Surg. 2019;269:e16-e17.
    PubMed    


  119. GIULIANTE F, Ardito F
    ALPPS Versus Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastases.
    Ann Surg. 2019;269:e15-e16.
    PubMed    


  120. MARGONIS GA, Andreatos N, Wolfgang CL, Weiss MJ, et al
    Reply to: "Decoding Tumor Biology of Colorectal Liver Metastases With Radiogenomics: A Novel Insight Into Surgical Approach Selection".
    Ann Surg. 2019;269:e4-e5.
    PubMed    


  121. JI GW, Wang K, Xia YX, Li XC, et al
    Decoding Tumor Biology of Colorectal Liver Metastases With Radiogenomics: A Novel Insight Into Surgical Approach Selection.
    Ann Surg. 2019;269:e3-e4.
    PubMed    


  122. PETERSSON J, Koedam TW, Bonjer HJ, Andersson J, et al
    Bowel Obstruction and Ventral Hernia After Laparoscopic Versus Open Surgery for Rectal Cancer in A Randomized Trial (COLOR II).
    Ann Surg. 2019;269:53-57.
    PubMed     Abstract available


  123. HABR-GAMA A, Sao Juliao GP, Vailati BB, Sabbaga J, et al
    Organ Preservation in cT2N0 Rectal Cancer After Neoadjuvant Chemoradiation Therapy: The Impact of Radiation Therapy Dose-escalation and Consolidation Chemotherapy.
    Ann Surg. 2019;269:102-107.
    PubMed     Abstract available


  124. SUNG SY, Jang HS, Kim SH, Jeong JU, et al
    Oncologic Outcome and Morbidity in the Elderly Rectal Cancer Patients After Preoperative Chemoradiotherapy and Total Mesorectal Excision: A Multi-institutional and Case-matched Control Study.
    Ann Surg. 2019;269:108-113.
    PubMed     Abstract available


  125. BRUDVIK KW, Jones RP, Giuliante F, Shindoh J, et al
    RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases.
    Ann Surg. 2019;269:120-126.
    PubMed     Abstract available


    December 2018
  126. NADALIN S, Capobianco I, Koenigsrainer A
    Response: "RAPID but Not Harmful: Functional Evaluation With Hepatobiliary Scintigraphy After Accelerated Liver Regeneration Techniques".
    Ann Surg. 2018 Dec 29. doi: 10.1097/SLA.0000000000003185.
    PubMed    


    November 2018
  127. FAUCHERON JL, Girard E, Trilling B
    Impact of the Primary Tumor Location on the Prognosis for Colon Cancer: Adjustment for Bias Could Lead to Other Conclusions.
    Ann Surg. 2018 Nov 22. doi: 10.1097/SLA.0000000000003099.
    PubMed    


    August 2018
  128. GAO Z, Wang C, Cui Y, Shen Z, et al
    Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer: Three-year Results From a Prospective, Nonrandomized, Double-blind, Controlled Trial.
    Ann Surg. 2018 Aug 24. doi: 10.1097/SLA.0000000000003012.
    PubMed     Abstract available


  129. BHANGU JS, Beer A, Mittlbock M, Tamandl D, et al
    Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver Metastasis.
    Ann Surg. 2018 Aug 3. doi: 10.1097/SLA.0000000000002901.
    PubMed     Abstract available


    July 2018
  130. YUN L, Zhiwei J, Kehlet H, Gang W, et al
    Is an Extensive ERAS Program Able to Bring a Better Outcome in Contrast With Standard ERAS Program for Laparoscopic Colorectal Cancer Surgery?
    Ann Surg. 2018 Jul 2. doi: 10.1097/SLA.0000000000002848.
    PubMed    


    May 2018
  131. RENAUD S, Seitlinger J, Lawati YA, Guerrera F, et al
    Anatomical Resections Improve Survival Following Lung Metastasectomy of Colorectal Cancer Harboring KRAS Mutations.
    Ann Surg. 2018 May 17. doi: 10.1097/SLA.0000000000002829.
    PubMed     Abstract available


    April 2018
  132. VALLANCE AE, Keller DS, Hill J, Braun M, et al
    Role of Emergency Laparoscopic Colectomy for Colorectal Cancer: A Population-Based Study in England.
    Ann Surg. 2018 Apr 4. doi: 10.1097/SLA.0000000000002752.
    PubMed     Abstract available


  133. STOMMEL MWJ, Ten Broek RPG, Strik C, Slooter GD, et al
    Multicenter Observational Study of Adhesion Formation After Open-and Laparoscopic Surgery for Colorectal Cancer.
    Ann Surg. 2018;267:743-748.
    PubMed     Abstract available


    March 2018
  134. ZHANG K, Chen L
    A Highly Predictive Model for Diagnosis of Colorectal Neoplasms Using Plasma MicroRNA: Improving Specificity and Sensitivity.
    Ann Surg. 2018;267:e57-e58.
    PubMed    


  135. YAMASHITA S, Brudvik KW, Kopetz SE, Maru D, et al
    Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases.
    Ann Surg. 2018;267:514-520.
    PubMed     Abstract available


  136. SAMMOUR T, Malakorn S, Bednarski BK, Kaur H, et al
    Oncological Outcomes After Robotic Proctectomy for Rectal Cancer: Analysis of a Prospective Database.
    Ann Surg. 2018;267:521-526.
    PubMed     Abstract available


  137. SUZUKI Y, Okabayashi K, Hasegawa H, Tsuruta M, et al
    Comparison of Preoperative Inflammation-based Prognostic Scores in Patients With Colorectal Cancer.
    Ann Surg. 2018;267:527-531.
    PubMed     Abstract available


    February 2018
  138. BEPPU T, Yamamoto M
    Laparoscopic Versus Open Liver Resection for Colorectal Liver Metastases-Which Is a More Suitable Standard Practice?
    Ann Surg. 2018;267:208-209.
    PubMed    


  139. TURNER MC, Adam MA, Sun Z, Kim J, et al
    Response to Letter: Comment on "Insurance Status, Not Race Is Associated With Use of Minimally Invasive Surgical Approach for Rectal Cancer".
    Ann Surg. 2018;267:e30.
    PubMed    


  140. GABRIEL E, Al-Sukhni E, Nurkin S
    Commentary on "Insurance Status, Not Race, is Associated With Use of Minimally Invasive Surgical Approach for Rectal Cancer".
    Ann Surg. 2018;267:e29-e30.
    PubMed    


  141. GIACCAGLIA V, Antonelli MS, Salvi PF, Nigri G, et al
    CRP Predicts Safe Patient Discharge After Colorectal Surgery: Reply.
    Ann Surg. 2018;267:e33-e34.
    PubMed    


  142. DUPRE A, Gagniere J, Samba H, Rivoire M, et al
    CRP Predicts Safe Patient Discharge After Colorectal Surgery.
    Ann Surg. 2018;267:e33.
    PubMed    


  143. FRETLAND AA, Dagenborg VJ, Bjornelv GMW, Kazaryan AM, et al
    Laparoscopic Versus Open Resection for Colorectal Liver Metastases: The OSLO-COMET Randomized Controlled Trial.
    Ann Surg. 2018;267:199-207.
    PubMed     Abstract available


  144. KIM MJ, Park SC, Park JW, Chang HJ, et al
    Robot-assisted Versus Laparoscopic Surgery for Rectal Cancer: A Phase II Open Label Prospective Randomized Controlled Trial.
    Ann Surg. 2018;267:243-251.
    PubMed     Abstract available


  145. BUCHLI C, Martling A, Abani MA, Frodin JE, et al
    Risk of Acute Testicular Failure After Preoperative Radiotherapy for Rectal Cancer: A Prospective Cohort Study.
    Ann Surg. 2018;267:326-331.
    PubMed     Abstract available


    January 2018
  146. SASAKI K, Morioka D, Conci S, Margonis GA, et al
    The Tumor Burden Score: A New "Metro-ticket" Prognostic Tool For Colorectal Liver Metastases Based on Tumor Size and Number of Tumors.
    Ann Surg. 2018;267:132-141.
    PubMed     Abstract available


    December 2017
  147. YAMASHITA S, Sheth RA, Niekamp AS, Aloia TA, et al
    Comprehensive Complication Index Predicts Cancer-specific Survival After Resection of Colorectal Metastases Independent of RAS Mutational Status.
    Ann Surg. 2017;266:1045-1054.
    PubMed     Abstract available


  148. CHI P, Chen Z, Lu X
    Transanal Total Mesorectal Excision: Can it Achieve the Standard of TME?
    Ann Surg. 2017;266:e87-e88.
    PubMed    


  149. SMITH FM, Rooney P, Farrell C
    Does MRI Restaging of Rectal Cancer After Chemoradiotherapy Actually Permit a Change in Surgical Management?
    Ann Surg. 2017;266:e104-e105.
    PubMed    


  150. BATTERSBY NJ, Moran B, Stelzner S, West NP, et al
    Reply to: Does MRI Restaging of Rectal Cancer After Chemoradiotherapy Actually Permit a Change in Surgical Management?
    Ann Surg. 2017;266:e116-e118.
    PubMed    


  151. MONSON JRT, Arsalanizadeh R
    Transanal Total Mesorectal Excision (TaTME) and Quality of Rectal Cancer Surgery: Do we Really Know?
    Ann Surg. 2017;266:e88-e89.
    PubMed    


    November 2017
  152. MARKAR SR, Chin ST, Romano A, Wiggins T, et al
    Breath Volatile Organic Compound Profiling of Colorectal Cancer Using Selected Ion Flow-Tube Mass Spectrometry.
    Ann Surg. 2017 Nov 29. doi: 10.1097/SLA.0000000000002539.
    PubMed     Abstract available


  153. MAGGIORI L, Rullier E, Lefevre JH, Regimbeau JM, et al
    Does a Combination of Laparoscopic Approach and Full Fast Track Multimodal Management Decrease Postoperative Morbidity?: A Multicenter Randomized Controlled Trial.
    Ann Surg. 2017;266:729-737.
    PubMed     Abstract available


  154. LINECKER M, Bjornsson B, Stavrou GA, Oldhafer KJ, et al
    Risk Adjustment in ALPPS Is Associated With a Dramatic Decrease in Early Mortality and Morbidity.
    Ann Surg. 2017;266:779-786.
    PubMed     Abstract available


  155. BORSTLAP WAA, Westerduin E, Aukema TS, Bemelman WA, et al
    Anastomotic Leakage and Chronic Presacral Sinus Formation After Low Anterior Resection: Results From a Large Cross-sectional Study.
    Ann Surg. 2017;266:870-877.
    PubMed     Abstract available


  156. VELLINGA TT, Kranenburg O, Frenkel N, Ubink I, et al
    Lymphangiogenic Gene Expression Is Associated With Lymph Node Recurrence and Poor Prognosis After Partial Hepatectomy for Colorectal Liver Metastasis.
    Ann Surg. 2017;266:765-771.
    PubMed     Abstract available


    October 2017
  157. RAHBARI NN, Carr PR, Jansen L, Chang-Claude J, et al
    Time of Metastasis and Outcome in Colorectal Cancer.
    Ann Surg. 2017 Oct 23. doi: 10.1097/SLA.0000000000002564.
    PubMed     Abstract available


  158. KELLEY KA, Ruhl RA, Rana SR, Dewey E, et al
    Understanding and Resetting Radiation Sensitivity in Rectal Cancer.
    Ann Surg. 2017;266:610-616.
    PubMed     Abstract available


  159. MARGONIS GA, Buettner S, Andreatos N, Sasaki K, et al
    Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases.
    Ann Surg. 2017;266:641-649.
    PubMed     Abstract available


  160. SUJATHA-BHASKAR S, Jafari MD, Gahagan JV, Inaba CS, et al
    Defining the Role of Minimally Invasive Proctectomy for Locally Advanced Rectal Adenocarcinoma.
    Ann Surg. 2017;266:574-581.
    PubMed     Abstract available


    August 2017
  161. SAMMOUR T, Chang GJ
    Lateral Node Dissection in Low Rectal Cancer: Time for a Global Approach?
    Ann Surg. 2017;266:208-209.
    PubMed    


    April 2017
  162. ZHOU H, Ruan C, Hu Z
    Perineal Transanal Approach for Laparoscopic Sphincter-saving Resection in Low Rectal Cancer.
    Ann Surg. 2017;265:e32-e33.
    PubMed    


  163. SMITH FM, Winter D
    Pathologic Complete Response of Primary Tumor Following Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Long-term Outcomes and Prognostic Significance of Pathologic Nodal Status (KROG 09-01).
    Ann Surg. 2017;265:e27-e28.
    PubMed    


  164. RAPTIS DA, Bachler T, Nocito A, Bueter M, et al
    Obesity Surgery and the Risk of Colorectal Carcinoma-Searching for the Fly in the Ointment?
    Ann Surg. 2017;265:e29-e30.
    PubMed    


  165. RUI YY, Zhou ZG, Wang C, Yang L, et al
    Are We Ready for Extralevatory Abdominoperineal Excision?
    Ann Surg. 2017;265:e55-e56.
    PubMed    


  166. EVRARD S, Poston G
    Response to Faitot et al "Two-stage Hepatectomy Versus 1-Stage Resection Combined With Radiofrequency for Bilobar Colorectal Metastases: A Case-matched Analysis of Surgical and Oncological Outcomes".
    Ann Surg. 2017;265:e52-e53.
    PubMed    


  167. CHEN WH, Luo SL, Kang L
    Transanal Total Mesorectal Excision: Will It Be A Valid Alternative in Rectal Cancer Surgery?
    Ann Surg. 2017;265:e36-e37.
    PubMed    


    March 2017
  168. MISE Y, Hasegawa K, Satou S, Shindoh J, et al
    How Has Virtual Hepatectomy Changed the Practice of Liver Surgery?: Experience of 1194 Virtual Hepatectomy Before Liver Resection and Living Donor Liver Transplantation.
    Ann Surg. 2017 Mar 10. doi: 10.1097/SLA.0000000000002213.
    PubMed     Abstract available


    January 2017
  169. KALADY MF
    Seeing the Trees For the Forest: Rectal Cancer Intratumoral Heterogeneity.
    Ann Surg. 2017;265:e7.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: